Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
10/16/2023
Jolynn Tumolo
Results of a recent study show greater clinical and economic benefit regardless of previous treatment.
Results of a recent study show greater clinical and economic benefit regardless of previous treatment.
Results of a recent study show...
10/16/2023
Pharmacy Learning Network
News
10/16/2023
Jolynn Tumolo
A traditional, siloed approach has hampered the development of gene-targeted therapies for rare diseases. The need for a more collaborative approach was discussed at a 3-day virtual meeting hosted in 2021 by the National Institutes of Health,...
A traditional, siloed approach has hampered the development of gene-targeted therapies for rare diseases. The need for a more collaborative approach was discussed at a 3-day virtual meeting hosted in 2021 by the National Institutes of Health,...
A traditional, siloed approach...
10/16/2023
Integrated Healthcare Executive
News
10/13/2023
Jolynn Tumolo
“If the [US] wants to appropriately price drugs and contain their costs and avoid the downsides of international reference pricing, it should also conduct its own assessments to determine how much drugs are worth and negotiate from that...
“If the [US] wants to appropriately price drugs and contain their costs and avoid the downsides of international reference pricing, it should also conduct its own assessments to determine how much drugs are worth and negotiate from that...
“If the [US] wants to...
10/13/2023
Pharmacy Learning Network
News
10/13/2023
Jolynn Tumolo
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that...
10/13/2023
First Report Managed Care
News
10/13/2023
Jolynn Tumolo
A study found that only 1.2% of primary care providers offered Intensive Behavioral Therapy (IBT) services over 7 years, with some being consistent users, early adopters, and late adopters.
A study found that only 1.2% of primary care providers offered Intensive Behavioral Therapy (IBT) services over 7 years, with some being consistent users, early adopters, and late adopters.
A study found that only 1.2% of...
10/13/2023
First Report Managed Care
News
10/13/2023
Jolynn Tumolo
A study revealed significant variation in RSV testing rates across different types of hospitals, with higher testing rates observed in larger, teaching, and urban hospitals compared to their counterparts.
A study revealed significant variation in RSV testing rates across different types of hospitals, with higher testing rates observed in larger, teaching, and urban hospitals compared to their counterparts.
A study revealed significant...
10/13/2023
Pharmacy Learning Network
News
10/12/2023
Jolynn Tumolo
Concerns of bacterial and fungal contamination have prompted the recall of more than 6000 bottles of Dr Berne’s MSM Drops 15% Solution. The recall was included in the October 11, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Concerns of bacterial and fungal contamination have prompted the recall of more than 6000 bottles of Dr Berne’s MSM Drops 15% Solution. The recall was included in the October 11, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Concerns of bacterial and fungal...
10/12/2023
Pharmacy Learning Network
News
10/11/2023
Jolynn Tumolo
Zydus Pharmaceuticals (USA) Inc. is recalling 7248 bottles of oxybutynin chloride extended-release tablets after samples failed to meet dissolution specifications during routine testing, according to the October 11, 2023, US Food and Drug...
Zydus Pharmaceuticals (USA) Inc. is recalling 7248 bottles of oxybutynin chloride extended-release tablets after samples failed to meet dissolution specifications during routine testing, according to the October 11, 2023, US Food and Drug...
Zydus Pharmaceuticals (USA) Inc....
10/11/2023
Pharmacy Learning Network
News
10/11/2023
Jolynn Tumolo
Amerisource Health Services voluntarily initiated the recall September 1, 2023. The FDA designated the recall Class III on October 5, 2023. Per the Class III designation, use of the affected tablets is not likely to cause harm.
Amerisource Health Services voluntarily initiated the recall September 1, 2023. The FDA designated the recall Class III on October 5, 2023. Per the Class III designation, use of the affected tablets is not likely to cause harm.
Amerisource Health Services...
10/11/2023
Pharmacy Learning Network
A man with depressive symptoms looks out the window
News
10/11/2023
Jolynn Tumolo
Before the onset of multiple sclerosis (MS), patients are nearly twice as likely to experience psychiatric comorbidity, according to a study published in Neurology.
Before the onset of multiple sclerosis (MS), patients are nearly twice as likely to experience psychiatric comorbidity, according to a study published in Neurology.
Before the onset of multiple...
10/11/2023
Neurology